Exploring the intricacies of adrenal gland cancer stands as a beacon in oncological research, despite its rarity. Nestled atop the kidneys, these glands wield immense influence over hormonal balance, making them prime targets for malignancy. Unraveling the genetic tapestry driving these tumors forms the cornerstone of tailored treatment modalities. From the pursuit of novel biomarkers for early detection to the fine-tuning of immunotherapeutic and targeted interventions, the landscape of adrenal cancer research is dynamic. Innovations in imaging techniques further illuminate pathways for precise diagnosis and monitoring. Through interdisciplinary collaborations and relentless pursuit of breakthroughs, the collective effort converges towards a brighter horizon, offering renewed hope for patients grappling with adrenal gland cancer.
Title :
Pietro Salvatori, Private Practice, Italy
Title :
Jianhua Luo, University of Pittsburgh, United States
Title :
Marika Crohns, Sanofi, Germany
Title : RNA binding proteins in the pathogenesis of pediatric cancer
Atif A Ahmed, University of Washington-Seattle Children’s Hospital, United States
Title : A novel mRNA genomic technology for precision medicine, early cancer diagnosis, prognosis, treatment follow-up and cancer gene therapy
Rajvir Dahiya, University of California San Francisco, United States
Title : The future of pharmacogenetic polymorphism, pharmacogenomics and pharmamicrobiome in cancer treatment
Bene Ekine-Afolabi, University of East London, United Kingdom